Passions

Cal Football

Vintage Guitars and Amplifiers

Nana’s Lasagna

Experience

Allay Therapeutics Secures $57.5 Million Series D

June 5, 2025

Cooley advised Allay Therapeutics, a clinical-stage biotechnology company pioneering ultrasustained analgesic products to transform postsurgical pain management and recuperation, on its $57.5 million Series D financing.

Read more

Related contacts

Mark Weeks
Partner, Palo Alto
Michael Perretta
Associate, Palo Alto

Related Practices & Industries

Inventiva – $108 Million IPO

July 22, 2020

Cooley advised Inventiva on its $107.7 million initial public offering of 7,478,261 American Depositary Shares or ADSs. Inventiva, whose securities now trade on the Nasdaq Global Market and Euronext Paris under the symbol “IVA,” is a clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies for the treatment of NASH, MPS and other diseases with significant unmet medical need. Partners Div Gupta, Rich Segal, and Alison Haggerty led the Cooley team.

Related contacts

Div Gupta
Partner, New York
Richard Segal
Partner, New York
Michael Perretta
Associate, Palo Alto

Related Practices & Industries

Bolt Biotherapeutics – $264.5 Million IPO

Cooley advised Bolt Biotherapeutics on its $264.50 million initial public offering of 13,225,000 shares of common stock, which includes the exercise in full of the underwriters’ option to purchase an additional 1,725,000 shares. Bolt Biotherapeutics, whose securities now trade on the Nasdaq Global Market under the symbol “BOLT,” is a clinical-stage immuno-oncology company developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems. Partners John McKenna and Sonya Erickson led the Cooley team.

Related contacts

John McKenna
Partner, Palo Alto
Sonya Erickson
Partner and Business Department Chair, Seattle
Colleen Badgley
Partner, Seattle
Kate Nichols
Partner, Palo Alto
Michael Perretta
Associate, Palo Alto

Admissions and credentials

California

Memberships and affiliations

American Bar Association (ABA)

The State Bar of California

This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as "Cooley"). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction, and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. When advising companies, our attorney-client relationship is with the company, not with any individual. This content may have been generated with the assistance of artificial intelligence (Al) in accordance with our Al Principles, may be considered Attorney Advertising and is subject to our legal notices.